Shares of USANA Health Sciences, Inc. (NYSE:USNA - Get Free Report) crossed above its 200-day moving average during trading on Monday . The stock has a 200-day moving average of $30.46 and traded as high as $31.34. USANA Health Sciences shares last traded at $30.58, with a volume of 142,093 shares traded.
Wall Street Analyst Weigh In
Separately, Wall Street Zen upgraded USANA Health Sciences from a "hold" rating to a "buy" rating in a research note on Thursday, May 22nd.
Check Out Our Latest Stock Analysis on USANA Health Sciences
USANA Health Sciences Price Performance
The company's 50 day simple moving average is $29.95 and its 200 day simple moving average is $30.43. The company has a market capitalization of $610.18 million, a PE ratio of 18.01, a price-to-earnings-growth ratio of 1.05 and a beta of 0.64.
USANA Health Sciences (NYSE:USNA - Get Free Report) last posted its earnings results on Tuesday, April 22nd. The company reported $0.73 EPS for the quarter, beating analysts' consensus estimates of $0.70 by $0.03. USANA Health Sciences had a net margin of 3.98% and a return on equity of 8.94%. The firm had revenue of $249.54 million for the quarter, compared to the consensus estimate of $243.08 million. During the same period last year, the firm posted $0.86 EPS. On average, equities analysts forecast that USANA Health Sciences, Inc. will post 2.45 EPS for the current year.
Insider Transactions at USANA Health Sciences
In other USANA Health Sciences news, COO Walter Noot sold 6,291 shares of USANA Health Sciences stock in a transaction on Tuesday, May 27th. The shares were sold at an average price of $30.29, for a total value of $190,554.39. The transaction was disclosed in a document filed with the SEC, which is available through this link. Also, CFO G Doug Iiekking sold 4,548 shares of the company's stock in a transaction dated Friday, May 9th. The shares were sold at an average price of $29.61, for a total transaction of $134,666.28. The disclosure for this sale can be found here. Over the last three months, insiders sold 12,013 shares of company stock valued at $360,149. Insiders own 0.63% of the company's stock.
Hedge Funds Weigh In On USANA Health Sciences
Several institutional investors have recently added to or reduced their stakes in the stock. US Bancorp DE raised its position in USANA Health Sciences by 13.1% during the 1st quarter. US Bancorp DE now owns 4,611 shares of the company's stock worth $124,000 after buying an additional 535 shares during the last quarter. Exchange Traded Concepts LLC increased its holdings in shares of USANA Health Sciences by 7.1% in the 1st quarter. Exchange Traded Concepts LLC now owns 9,184 shares of the company's stock valued at $248,000 after purchasing an additional 606 shares in the last quarter. PNC Financial Services Group Inc. lifted its stake in shares of USANA Health Sciences by 339.6% in the first quarter. PNC Financial Services Group Inc. now owns 998 shares of the company's stock valued at $27,000 after purchasing an additional 771 shares during the period. Martingale Asset Management L P lifted its stake in shares of USANA Health Sciences by 5.4% in the first quarter. Martingale Asset Management L P now owns 17,542 shares of the company's stock valued at $473,000 after purchasing an additional 900 shares during the period. Finally, Versant Capital Management Inc boosted its holdings in USANA Health Sciences by 542.5% during the first quarter. Versant Capital Management Inc now owns 1,150 shares of the company's stock worth $31,000 after buying an additional 971 shares in the last quarter. Institutional investors and hedge funds own 54.25% of the company's stock.
USANA Health Sciences Company Profile
(
Get Free Report)
USANA Health Sciences, Inc develops, manufactures, and sells science-based nutritional, personal care, and skincare products in the Asia Pacific, the Americas, and Europe. The company offers USANA nutritional products that comprise essentials/CellSentials, such as vitamin and mineral supplements that provide a foundation of total body nutrition for various age groups; optimizers consisting of targeted supplements that are designed to meet cardiovascular, skeletal/structural, and digestive health needs; and food that include meal replacement shakes, snack bars, and other related products.
Read More
Before you consider USANA Health Sciences, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and USANA Health Sciences wasn't on the list.
While USANA Health Sciences currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
With the proliferation of data centers and electric vehicles, the electric grid will only get more strained. Download this report to learn how energy stocks can play a role in your portfolio as the global demand for energy continues to grow.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
